Lymphoma Research Foundation
In research, Lymphoma Research Foundation stands highest in Medicine (#8,815 of 17,978 worldwide) and Health Sciences (#11,701 of 20,462 worldwide), over all time.
- World rank, all time
- #18,560 of 42,892
- Rank in United States
- #4,034 of 8,685
- Research works
- 309 ▼ 10% vs 2013–17
- Citations
- 12k 40.0 per fractional work
- Top-10% rate
- 8.9% record average 16.5%
- Open access
- 26% world 28%
What is Lymphoma Research Foundation known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #8,815 of 17,978 | 21.0% | 226 | |
| Health SciencesDomain | #11,701 of 20,462 | 21.0% | 228 |
Each strip is that field’s whole ranked pool, with the notch where Lymphoma Research Foundation sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.5×. Every wedge is a field page.
- Medicine 3.5×
- Decision Sciences 3.1×
- Immunology and Microbiology 2.4×
- Biochemistry, Genetics and Molecular Biology 1.3×
- Economics, Econometrics and Finance 1.0×
- Business, Management and Accounting 0.9×
- Social Sciences 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Computer Science 0.4×
- Engineering 0.2×
- Materials Science 0.1×
- Health Professions 0.0×
Which keywords describe research at Lymphoma Research Foundation?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Rituximab, Lymphoma, Prognostic Factors, Therapeutic Targets, Chronic Lymphocytic Leukemia, Genomic Aberrations, PET Imaging and Classification.
- Climate Change
- CAR T Cells
- Cancer Immunotherapy
- Immunotherapy
- Classification
- Therapeutic Targets
- Chronic Lymphocytic Leukemia
- Lymphoma
- Rituximab
- Prognostic Factors
- Genomic Aberrations
- PET Imaging
- Molecular Profiling
- Leukemia
- Tumor Regression
- Chimeric Antigen Receptor
- Renewable Energy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Rituximab7▲ 226×2 topics
- Lymphoma5▲ 152×3 topics
- Prognostic Factors5▲ 54×6 topics
- Chronic Lymphocytic Leukemia4▲ 397×1 topic
- Genomic Aberrations4▲ 397×1 topic
- Therapeutic Targets4▲ 118×2 topics
- PET Imaging4▲ 96×2 topics
- Classification4▲ 35×1 topic
- Molecular Profiling4▲ 163×1 topic
- Immunotherapy2▲ 13×5 topics
- Leukemia2▲ 100×2 topics
- Cancer Immunotherapy2▲ 53×3 topics
- Tumor Regression2▲ 71×2 topics
- CAR T Cells2▲ 102×1 topic
- Chimeric Antigen Receptor2▲ 102×1 topic
- Climate Change1▲ 2.3×2 topics
- Renewable Energy1▲ 4.2×2 topics
Which research topics does Lymphoma Research Foundation publish most on?
By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research and Innovative Approaches in Technology and Social Development.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 4 works
- 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 4 works
- 3 CAR-T cell therapy research Oncology 2 works
- 4 Innovative Approaches in Technology and Social Development Management of Technology and Innovation 1 works
- 5 ICT in Developing Communities Information Systems 1 works
- 6 Integrated Energy Systems Optimization Electrical and Electronic Engineering 1 works
- 7 demographic modeling and climate adaptation Management Science and Operations Research 1 works
- 8 Healthcare Facilities Design and Sustainability Urban Studies 1 works
- 9 Social Acceptance of Renewable Energy Sociology and Political Science 1 works
- 10 Cutaneous lymphoproliferative disorders research Dermatology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Lymphoma Research Foundation's research output changed?
Output in 2018–2022 was 10% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in New York
- Columbia University
- New York University
- Icahn School of Medicine at Mount Sinai
- Memorial Sloan Kettering Cancer Center
- City University of New York
- Human Growth Foundation
- Columbia University Irving Medical Center
- Rockefeller University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.